icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
 Back grey_arrow_rt.gif
 
 
 
BULEVIRTIDE MONOTHERAPY PREVENTS LIVER DECOMPENSATION IN HDV-RELATED CIRRHOSIS: 3-YEAR RESULTS FROM A EUROPEAN, RETROSPECTIVE, CONTROLLED COHORT STUDY oral
 
 
  AASLD 2026 Denver
 

1108261opy

1108262copy

1108263copy

1108264copy

1108265copy

1108266copycopy

1108267copy

1108268copy

1108269copy

11082610copy